Faculty
Alexandra Miere
Country:
Affiliation:
Webinar
Hot topics
EC approves Brolucizumab for the treatment of DME
The European Commission has granted approval to Beovu® 6mg (brolucizumab, Novartis) for the treatment of visual impairment related to diabetic macular oedema. Read more